来自明尼苏达州奥尔姆斯特德县的心力衰竭和保存的喷射分数患者的心脏结构和心室血管功能
Carolyn S P Lam1, Véronique L Roger, Richard J Rodeheffer
1Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905, USA.
Circulation
|April 4, 2007
概括
正常喷射分数 (HFnlEF) 的心力衰竭与扩张功能受损和硬度增加有关. 扩张性功能障碍的进展是高血压心脏病的关键,影响HFnlEF的发展.
科学领域:
- 心脏病学 心脏病学
- 生理学 生理学 生理学
背景情况:
- 正常射出分数 (HFnlEF) 的心力衰竭病理生理学涉及透支功能障碍,硬化和体积膨胀.
- 在HFnlEF中对心脏机制的非侵入性表征对于了解疾病进展至关重要.
研究的目的:
- 在HFnlEF患者和对照者中,以非侵入的方式来表征左心室体积,动脉弹性和心室弹性和放松.
- 调查透支功能障碍在HFnlEF发展中的作用.
主要方法:
- 没有心血管疾病,高血压和HFnlEF的个体的未来招生.
- 利用回声多普勒检测终端透气体体积,血压,中风体积和射出分数,以确定弹性参数.
- 组织多普勒和透气曲线适配 (α和β常数) 用于评估放松和刚性.
主要成果:
- 与对照组相比,HFnlEF患者表现出较小的终端透析体积指数和心脏输出量,并增加了终端透析压力.
- 动脉和心室末缩弹性在高血压对照和HFnlEF患者和健康对照中升高.
- 与两组对照组相比,HFnlEF患者表现出更严重的放松障碍和扩张性硬度增加.
结论:
- 扩张性功能障碍的进展是HFnlEF发展的重要因素,特别是在高血压心脏病中.
- 非侵入性评估揭示了HFnlEF中明显的机械异常,强调了透缩功能障碍.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


